- 0
- 0
- 约小于1千字
- 约 24页
- 2018-02-13 发布于天津
- 举报
Thrombomodulin Enhances the Therapeutic Effects of Human Circulating Progenitor Cells in Ischemic Limb;Introduction;Overview of clinical studies evaluating different cell types ;centrifugation;Two different types of cultured MNC;How to enhance the therapeutic potential of EPC in ischemic disease? ;Thrombomodulin (TM) ;TM expression in human PBMNC cultured in different medium;80;CFU in PBMNC respectively treated with TMD1, TMD23 and TMD123 (100 ng/ml);Gelatin zymography of early EPC treated with TMD23 (100 ng/ml) for 72 hour;Western blotting of early EPC treated with TMD23 (100 ng/ml);Group;Effects of combined TMD23 and early EPCs in murine hindlimb ischemia model;PBS/saline;M-PECAM-1 / Laminin;50 mm;20;Summary;Conclusion;Thanks for your attention
原创力文档

文档评论(0)